Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

  1. Lipton, R.B.
  2. Brennan, A.
  3. Palmer, S.
  4. Hatswell, A.J.
  5. Porter, J.K.
  6. Sapra, S.
  7. Villa, G.
  8. Shah, N.
  9. Tepper, S.
  10. Dodick, D.
Revista:
Journal of Medical Economics

ISSN: 1941-837X 1369-6998

Any de publicació: 2018

Volum: 21

Número: 7

Pàgines: 666-675

Tipus: Article

DOI: 10.1080/13696998.2018.1457533 GOOGLE SCHOLAR